Table 1.
Without Diabetes Mellitus (N = 1,897,907) | With Diabetes Mellitus (N = 900,402) | P | |
---|---|---|---|
Age, y (mean ± SD) | 71.8 ± 6.6 | 72.1 + 6.5 | <0.001 |
BMI, kg/m2 (mean ± SD) | 28.0 ± 4.7 | 30.1 ± 5.4 | <0.001 |
Race, % | |||
White | 71.7 | 71.2 | <0.001 |
Black | 7.6 | 10.2 | |
Other | 3.4 | 5.0 | |
Unknown | 17.3 | 13.6 | |
Femoral BMD T scorea | −0.51 ± 1.44 | −0.28 ± 1.45 | <0.001 |
Comorbidities, % | |||
Alcohol abuse | 18.1 | 17.5 | <0.001 |
Tobacco use | 22.5 | 20.1 | <0.001 |
Rheumatoid arthritis | 0.7 | 0.5 | <0.001 |
Corticosteroid use | 1.7 | 1.6 | 0.19 |
Chronic kidney disease | |||
Stage 3 | 22.7 | 27.7 | <0.001 |
Stage 4/5 | 0.9 | 2.0 | |
Neuropathy | 13.6 | 23.8 | <0.001 |
Cardiovascular disease | 8.4 | 11.2 | <0.001 |
Cerebrovascular disease | 0.65 | 1.00 | <0.001 |
Congestive heart failure | 12.6 | 21.3 | <0.001 |
Chronic lung disease | 25.0 | 24.5 | <0.001 |
Chronic liver disease | 7.7 | 7.9 | <0.001 |
Seizure disorder | 3.9 | 4.8 | <0.001 |
Abbreviation: SD, standard deviation.
When available (N = 150,026).